Comparative Study of the Level of Atherogenic Markers; Remnant Cholesterol, Non-HDLc, Total Cholesterol-HDLc Ratio and LDLc-HDLc Ratio, in Overweight and Obese Subjects in Nnewi South East Nigeria
Asian Journal of Cardiology Research,
Background: Obesity elevates the risk of developing diabetes, coronary artery disease, fatty liver, gall stones, sleep apnea, arthritis and various types of cancer. Atherogenic indices have been suggested to be a link from obesity to coronary heart diseases, hence a predisposing factor in the development of cardiovascular disease by obese individuals. We looked at the level of these selected indices and their association with obesity.
Aim: The aim of this study is to evaluate and compare the Level of atherogenic markers concentration, in relation to body mass index of overweight and obese participants in Nnewi, South East Nigeria.
Methods: A total of 90 apparently healthy obese, overweight and normal weight participants who met the inclusion criteria were randomly enrolled into the study. They were grouped using their body mass index of 18.5 to 24.9 kg/m2 (normal weight), 25 to 29.9 kg/m2 (overweight) and ≥30 kg/m2 (obese). The parameters were measured using standard laboratory methods and statistical analysis was performed using SPSS 20.0.
Results: There was progressive increase of remnant cholesterol among the groups. There was no statistical difference (p>0.05) in the mean calculated remnant cholesterol (mmol/l) among the obese (0.72±0.4), overweight (0.68±0.46), and normal weight (0.50±0.28) participants. Mean fasting very low density lipoprotein (VLDL) and triglyceride (TG) (mmol/l) were significantly higher (p<0.05) in overweight and obese participants when compared to normal weight participants respectively, while plasma FBS levels (mmol/l) were significantly lower in normal weight participants when compared to overweight participants and obese participants. RC correlated negatively with non-HDLc and was not significant, but positively with TC/HDLc ratio and not significant also negatively significant with LDLc/HDLc ratio. In the overweight category, RC correlated negatively with non-HDLc, LDLc/HDLc but not significant and positively with TC/HDLc ratio but not significant. Finally in the obese group it was observed that RC correlated negatively with non-HDLc, positively with LDLc/HDLc and TC/HDLc ratio but was not significant.
Conclusion: The association of calculated remnant cholesterol with BMI is weak. Non-HDLc is strongly associated with obesity as well as TC/HDLc and LDLc/HDLc ratios. There was a negative correlation between calculated RC and non-HDLc. This suggests that remnant cholesterol can be elevated in any individual without apparent increase in BMI.
- Remnant cholesterol
- lipid profile
- post-prandial dyslipidemia
- atherogenic indices
How to Cite
Albuquerque D, Nóbrega C, Manco L, Padez C. The contribution of genetics and environment to obesity". British Medical Bulletin. 2017;123(1):159–173.
Iloh GUP, Amadi AN, Nwankwo BO, Ugwu VC. Obesity in adult Nigerians: a study of its pattern and common primary co-morbidities in a rural Mission General Hospital in Imo state, south-eastern Nigeria. Nigerian Journal of Clinical Practice. 2011;14(2).
Zhang, T., Cai, L., Ma, L., Jing, J., Chen, Y. and Ma, J. (2016) The Prevalence of Obesity and Influence of Early Life and Behavioral Factors on Obesity in Chinese Children in Guangzhou. BMC Public Health, 16, 954.
Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine. 2004;350(23):2362–2374.
Yusuf S. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497): 1640-9.
World Health Organization. The world health report: Reducing risks, promoting healthy lifestyles. Geneva; 2002.
Fatma M Al-Hakmani, Faiza A. Al-Fadhil, Lamia H. Al-Balushi, Norah A. Al-Harthy Zakiya A. Al-Bahri, Naama A. Al-Rawahi, Manal S. Al-Dhanki, Imrana Masoud, Nahal Afifi, Aisha Al-Alawi, Harikumar Padmakumar and Padmamohan J. Kurup. The Effect of Obesity on Pregnancy and its Outcome in the Population of Oman, Seeb Province. Oman Medical Journal. 2016;31(1):12–17.
Reddy KS. Cardiovascular disease in developing countries. Dimensions, determinants, dynamics and directions for public health action. Public Health Nutrition. 2002;5:231-7.
Virani SS, et al. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011;124(9):876-80 e2.
Njelekela M, Negishi H, Nara Y, Tomohiro M, Hinga S, Ngouchi T, et al. cardiovascular risk factors in Tanzania a revisit. Acta. Tropical. 2018;79:231-9.
Jorgensen AB, Frikke-schmidt R, West AS, Grand P, Nordestgaard BG, Tybearg-Hansen A. Genetically elevated non-fasting triglyceride and calculated cholesterol as a casual risk factor for myocardial infarction”. European Heart journal. 2013;34(24):1826-1833.
Nakajima K, Nakano T, Tanaka A. The Oxidative Modification hypothesis of Atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoprotein in the plasma. Clinical Chemistry Acta. 2006;367:37-47.
Ascaso J, González Santos P, Hernández Mijares A, et al. Management of dyslipidemia in the metabolic syndrome, recommendations of the Spanish HDL Forum. American Journal of Cardiovascular Drugs. 2007;7:39–58.
Allen CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total Serum Cholesterol. Clinical chemistry. 1974;20:470-475.
Trinder P. Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor. Annals of clinical biochemistry. 1969;6-24.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18 (6):499-502.
Keaven M. Anderson, Patricia M. Odell, Peter W.F. Wilson, William B. Kannel, Cardiovascular disease risk profiles. (1991). American Heart Journal. 1991;121(1), Part 2:293-298, ISSN 0002-8703,
Masoud Y Al-Maskari, Adel A Al-naqdy. Correlation between serum leptin levels, body mass index and obesity in Omanis. Sultan Qaboos University Medical Journal. 2006;6:27-31.
Farsi DJ, Elkhodary HM, Merdad, LA, Farsi NMA, Alaki SM, Alamoudi, NM, Bakhaidar, HA, Alolayyan MA. Prevalence of Obesity in Elementary School Children and Its Association with Dental Caries. Saudi Medical Journal. 2016;37:1387-1394.
Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinology of Metabolic Clinic North America. 2003;1(1):27-32.
Varbo A, Freiberg JJ, Nordestgaard BG. Remnant cholesterol and mayocadial infarction in normal weight, overweight, and obese individuals from copenhangen General Population Study”. Clinical Chemistry. 2018;64(1):219-230.
Denke MA, Sempos CT, SM. Grundy. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch International Medicine. 1993;153(9): 1093-103.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol. What treatments are recommended for high non-HDL-C levels? Atherosclerotic cardiovascular risk in adults: a report of the American College Of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of American College of Cardiology. 2014;63(25 Pt B): 2889-934.
Abstract View: 140 times
PDF Download: 41 times